VeriMompolybutylene glycol/mdi copolymer é seguro durante a gravidez?
No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
Related ingredients
Frequently asked questions
- polybutylene glycol/mdi copolymer é seguro durante a gravidez?
- No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).
- polybutylene glycol/mdi copolymer é seguro durante a amamentação?
- Same rationale as for pregnancy: no specific reproductive or lactation hazard identified for the polymer. Potential risk would stem from residual monomer (MDI) which is primarily a local irritant/sensitiser; no evidence that the polymer itself transfers into milk or causes systemic reproductive toxicity. No CIR/SCCS or harmonised CLP reproductive flags for the polymer were found.
- polybutylene glycol/mdi copolymer é seguro para a pele do bebê?
- Hazard and mechanism remain 0 for the polymer (no reproductive/teratogenic evidence). Exposure score increased by +1 for infants because infant skin has higher permeability and surface area:weight, so if any low‑MW residual MDI/oligomers are present they could have measurable absorption. However, the intact high‑MW polymer itself is expected to have negligible dermal absorption. Key concern is residual free MDI rather than the polymer.
- Como o VeriMom pontua polybutylene glycol/mdi copolymer?
- O VeriMom pontua polybutylene glycol/mdi copolymer em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a polybutylene glycol/mdi copolymer na gravidez?
- Veja nossa lista curada de alternativas seguras a polybutylene glycol/mdi copolymer com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.